BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4608944)

  • 41. Lead and polychlorinated biphenyls: effects on heme and drug metabolism.
    Alvares AP; Kappas A
    Drug Metab Rev; 1979; 10(1):91-106. PubMed ID: 118861
    [No Abstract]   [Full Text] [Related]  

  • 42. Drug kinetics and alcohol ingestion.
    Sellers EM; Holloway MR
    Clin Pharmacokinet; 1978; 3(6):440-52. PubMed ID: 31257
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of liver congestion on hepatic drug metabolism in the rat.
    Knodell RG; Farleigh RM; Steele NM; Bond JH
    J Pharmacol Exp Ther; 1982 Apr; 221(1):52-7. PubMed ID: 7062291
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Editorial: Drug metabolism in disease.
    Lancet; 1974 Apr; 1(7861):790-1. PubMed ID: 4132718
    [No Abstract]   [Full Text] [Related]  

  • 45. [Studies on the combination of drugs. V. Effect of 4-hydroxyantipyrine on the metabolism of amobarbital and pentobarbital].
    Niwa H; Nakayama T
    Yakugaku Zasshi; 1968 Jul; 88(7):843-6. PubMed ID: 5750524
    [No Abstract]   [Full Text] [Related]  

  • 46. Influence of prolonged recumbency on drug disposition.
    Kates RE; Harapat SR; Keefe DL; Goldwater D; Harrison DC
    Clin Pharmacol Ther; 1980 Nov; 28(5):624-8. PubMed ID: 7438681
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Drug disposition and dosing in hepatic disease.
    Somogyi A; Rolan P
    Med J Aust; 1986 Sep; 145(6):284-6, 289. PubMed ID: 3747914
    [No Abstract]   [Full Text] [Related]  

  • 48. Drugs in liver disease.
    Branch RA
    Clin Pharmacol Ther; 1998 Oct; 64(4):462-5. PubMed ID: 9797803
    [No Abstract]   [Full Text] [Related]  

  • 49. Aspects of drug metabolism relating to pharmacologic activity.
    Gillette JR
    Am J Pharm Sci Support Public Health; 1969; 141(2):64-75. PubMed ID: 4979429
    [No Abstract]   [Full Text] [Related]  

  • 50. Hepatic drug metabolizing capacity of patients of cirrhosis before and after clinico-biochemical recovery.
    Chauhan CK; Nanivadekar SA; Billimoria FR
    Indian J Physiol Pharmacol; 1989; 33(1):63-6. PubMed ID: 2737749
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mechanisms of inhibition of tolbutamide metabolism: phenylbutazone, oxyphenbutazone, sulfaphenazole.
    Pond SM; Birkett DJ; Wade DN
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):573-9. PubMed ID: 913025
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Intravenous tolbutamide test during hepatic disorders of chronic alcoholism].
    Cruz A; David H; Thervet F; Rambert P; Benard H
    Diabete; 1969; 17(1):29-32. PubMed ID: 5791572
    [No Abstract]   [Full Text] [Related]  

  • 53. Clinical pharmacokinetics.
    Atkinson AJ; Kushner W
    Annu Rev Pharmacol Toxicol; 1979; 19():105-27. PubMed ID: 378099
    [No Abstract]   [Full Text] [Related]  

  • 54. [Dosage of drugs with regard to their distribution volume and biological half-life].
    Dahl SG
    Tidsskr Nor Laegeforen; 1974 Jun; 94(18):1201-2. PubMed ID: 4839999
    [No Abstract]   [Full Text] [Related]  

  • 55. Altered plasma drug binding in cancer: role of alpha 1-acid glycoprotein and albumin.
    Jackson PR; Tucker GT; Woods HF
    Clin Pharmacol Ther; 1982 Sep; 32(3):295-302. PubMed ID: 7105620
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interindividual differences in rates of drug oxidation in man.
    Davies DS; Thorgeirsson SS; Breckenridge A; Orme M
    Drug Metab Dispos; 1973; 1(1):411-7. PubMed ID: 4149412
    [No Abstract]   [Full Text] [Related]  

  • 57. [A case of massive necrosis of the hemispheric white substance during treatment with Ambilhar in a cirrhotic female patient].
    Emerit J; Saigot T; Escourolle R; Bégué P
    Ann Med Interne (Paris); 1974 Jan; 125(1):65-9. PubMed ID: 4844156
    [No Abstract]   [Full Text] [Related]  

  • 58. Aminopyrine disposition: studies on breath, saliva, and urine of normal subjects and patients with liver disease.
    Hepner GW; Vesell ES
    Clin Pharmacol Ther; 1976 Dec; 20(6):654-60. PubMed ID: 991536
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mechanism of interaction of tolbutamide and phenylbutazone in diabetic patients.
    Ober KF
    Eur J Clin Pharmacol; 1974 Jul; 7(4):291-4. PubMed ID: 4853129
    [No Abstract]   [Full Text] [Related]  

  • 60. Fractional clearance of bromosulfonephthalein and metabolic clearance of antipyrine. Correlative study in liver diseases.
    Couet C; Brissot P; Messner M; Delamaire D; Gie S; Bourel M
    Ann Gastroenterol Hepatol (Paris); 1984; 20(1):1-6. PubMed ID: 6529154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.